SCHEMBL2293692

SCHEMBL2293692

CCCCC(C)c1cc(O)c(-c2c(O)cc(C(C)CCCC)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
XBP1 P17861 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALOX15 P16050 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
ATP2A2 P16615 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ATP2A3 Q93084 1/20 0.34
ADRB2 P07550 4/20 0.33
KDR P35968 1/20 0.33
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2289500 0.95 KDR (0.37) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL2290751 0.94 KDR (0.39) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL2293474 0.83 ALOX15 (0.40) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL2292908 0.83 NPSR1 (0.41) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL15064994 0.81 CYP1A2 (0.40) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL10081832 0.81 CA2 (0.42) GAAATMNPSR1ALOX15CYP2C9
SCHEMBL11805953 0.79 CA2 (0.41) GAAATMNPSR1ALOX15CYP2C9
SCHEMBL3117187 0.79 CA2 (0.41) GAAATMNPSR1ALOX15CYP2C9
SCHEMBL14976954 0.79 CA2 (0.41) GAAATMNPSR1ALOX15CYP2C9
SCHEMBL10775543 0.79 CA2 (0.41) GAAATMNPSR1ALOX15CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346887-B1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES DOW TECHNOLOGY INVESTMENTS LLC (US) 2013-12-25 EP disclosed
US-8546600-B2 Slurry process for synthesis of bisphosphites and situ use thereof for producing bisphosphite DOW TECHNOLOGY INVESTMENTS LLC 2013-10-01 US disclosed
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE DOW TECHNOLOGY INVESTMENTS LLC 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE SOST, PLCB3, PPIP5K2 GAA 4660/4885XBP1 3329/4885ATM 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.